Approval · Notice of Compliance 22883 · 2019
JAMP FLECAINIDE: Notice of Compliance 22883
Issued November 8, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22883
- Date
- November 8, 2019
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- APO-FLECAINIDE (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP FLECAINIDE | 02493705 | Marketed |
| JAMP FLECAINIDE | 02493713 | Marketed |
Medicinal ingredients
- FLECAINIDE ACETATE 50 MG per TAB
- FLECAINIDE ACETATE 100 MG per TAB